图书馆主页
数据库简介
最新动态
联系我们



返回首页


字顺( Alphabetical List of Journals):

A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


检 索:        高级检索

期刊名称:INTERNATIONAL JOURNAL OF DRUG POLICY

ISSN:0955-3959
出版频率:Monthly
出版社:ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
  出版社网址:http://www.elsevier.com/wps/find/homepage.cws_home
期刊网址:http://www.elsevier.com/wps/find/journaldescription.cws_home/600949/description#description
影响因子: 5.009 (2020年) 4.528(2018年) 4.244(2017年) 3.479(2016年) 3.119(2015年) 3.191(2014年) 2.475(2013年) 2.256 (2012年) 2.405(2011年)
主题范畴:SUBSTANCE ABUSE

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal
Description

The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.


Instructions to Authors
Guide for Authors

International Journal of Drug Policy

We welcome the submission of your manuscript.

We are happy to advise you on submissions. Please contact Gerry Stimson (gerry.stimson@ihra.net), Tim Rhodes (tim.rhodes@lshtm.ac.uk) or the Editorial Office at ijdp@elsevier.com.

Following the advice below will expedite the review of your manuscript. This advice is also available on the journal's website: External link http://www.elsevier.com/locate/drugpo.



The International Journal of Drug Policy is a bimonthly journal for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.

Readership

The journal has a broad readership drawn from the variety of disciplines working in the area of licit and illicit drug use and drug policy, including those working in social science, research and evaluation, health and community services, education and welfare, criminal justice, and policy development. The journal seeks an international readership.

Types of manuscripts

The journal encourages the submission of the following types of manuscript:

Editorials: These are usually between 1,500 and 2,500 words, and seek to raise a particular topic or issue for debate, no matter how controversial.

Commentaries: These are usually between 2,500 and 4,000 words, and seek to raise a particular topic or issue for debate. Occasionally, and given the consent of the author, the Editor may suggest inviting expert responses to commentaries for publication in the same issue.

Responses: Responses are short comments on papers published in the current or previous issues. They are usually between 500 and 1,000 words.

Reviews: These are usually between 4,000 and 8,000 words, and seek to review systematically a particular area of research, intervention, or policy. Occasionally, and given the consent of the author, the Editor may suggest inviting commentaries or responses to reviews.

Research papers: These are usually between 3,000 and 5,000 words, and exceptionally up to 7,000 words. These are usually based on original empirical research, but may also be discursive critical essays. Occasionally papers of a similar topic will be published as a 'special focus' within the same issue.

Policy and analysis: These occasional sections include commentaries and critical analysis with a focus upon drug policy developments, and are usually between 3,000 and 5,000 words, and exceptionally up to 7,000 words.

Letters and short reports: These are usually between 750 and 1,500 words, and comprise either letters to the Editor, preliminary findings, or short reports based on research.

Review essays: Review essays are extended commentaries on books, journal papers and other media, usually between 1,500 and 2,500 words. Review essays provide an opportunity for extensive critical discussion of contemporary books and other material such as film electronic information sources. Review essays also provide an opportunity to revisit classic books or journal papers; reviewers are invited to reflect on earlier work that has had a significant impact on the field in general or which has been a significant influence on the writer.

Book reviews: These are usually between 250 and 1,750 words. If you have read a recently published book on issues connected with drug use and/or drug policy which you would like to review, contact Gillian Hunter (gillian.hunter@kcl.ac.uk) to discuss whether it is appropriate for IJDP.

Submission of manuscripts

The journal welcomes manuscripts related to current research, reviews, debate and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit.

International Journal of Drug Policy uses an online, electronic submission system. By accessing the website External link http://ees.elsevier.com/drugpo/ you will be guided stepwise through the creation and uploading of the various files. When submitting a manuscript to Elsevier Editorial System, authors need to provide an electronic version of their manuscript. Authors may send queries concerning the submission process, manuscript status, or journal procedures to the Editorial Office:

IJDP, Editorial Office Health Sciences, ELSEVIER, Room 19.030, PO Box 993, 1000 AZ Amsterdam, The Netherlands.
E-mail: ijdp@elsevier.com
Tel: +31 (0) 20 485 3088
Fax: +31 (0) 20 485 3378

Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and request for revisions, will be by e-mail.

Authors' responsibilities

By submitting material for publication the authors warrant

•that it is their original work and that it has not been published in whole or in part elsewhere and is not under consideration by any other journal. If any part of the material has been or is being published elsewhere the authors should state this in an accompanying letter.
•that all persons named as authors have made a major contribution to the work reported, and are prepared to take public responsibility for its contents. Participation solely in the acquisition of funding or the collection of data does not justify authorship.

All authors must give signed consent to publication.

Conflict of interest

In order to make the best decision on a paper we should know about any competing interest that authors and reviewers of that paper may have.

We will not reject a paper simply because of an authors competing interest but we do publish statements on such interests.

Include in a covering letter any conflict of interest or state that there is no conflict of interest. A conflict of interest is where professional, personal, or financial considerations could be seen by a fair minded person as potentially in conflict with independence of judgement.

Ethics

It is the author's responsibility to ensure that work is of a high ethical standard.

What happens after we receive your manuscript?

Manuscript acknowledgement

Corresponding authors will be sent an acknowledgement that their manuscript has been received.

Review of manuscripts

Initial review: On receipt all manuscripts are seen by one of the Editors to assess overall suitability for publication in IJDP in terms of topic area and quality. A paper may be rejected at this stage if it falls outside the journals aims and scope; if there are obvious problems with presentation, argument or research; or if it is unoriginal.

Full peer view: After passing initial review submissions are assigned to one of the Editors or Assistant Editors. Manuscripts are sent to two or three peer reviewers. Reviewers advise the Editors, who are responsible for the final decision to accept or reject a manuscript. Peer reviewers are asked to respond within three weeks and are asked to rate the paper and to include comments for the Editors and for the authors. We aim to get a quick decision for authors, but review and appraisal by the editors is normally a minimum of eight weeks and can on occasions be longer. We aim to inform you if there is a delay. If you want information about progress please email the editorial office. All material accepted for publication may be subject to editorial revision. If your article is accepted for publication you will receive a proof copy from the Publisher. It is your responsibility to read, correct and return the proof within 48 hours.

Manuscript style

Please note the following when submitting manuscripts:

?On the first page, include the title of the paper, all authors first name and last name in full. Full corresponding author contact details should include email and fax number.
?On the second page, include the title of the paper, between 3-6 keywords, and an abstract of between 150 and 300 words.
?Structured abstract: Research papers, Review papers, Policy Analysis, Historical Analysis and Short reports should contain a structured abstract. Please adhere to the following mandatory abstract headings: background, methods, results, conclusion.
?Plain abstract: Commentaries and Review Essays should contain a plain abstract.
?No abstract: Editorials, Book reviews, Letters, Responses.
?Please write in a clear style for an international readership. We are an international journal and many of our readers do not have English as a first language. Avoid (or explain) colloquialisms.
?Keep the text style and sub-headings simple. Text should preferably be in Times New Roman or Aerial, 10-12 font, with double line spacing.
?Spelling is English (not American)
?All pages should be numbered at the bottom
?We do not normally like footnotes (but recognise that they are necessary for some styles of writing. Only use footnotes when absolutely necessary (otherwise incorporate into text).
?Keep tables simple. Do not duplicate information in the text. Include all tables and figures on separate sheets at the end; indicate in the text where these should be placed.
•Include in the acknowledgements any funding source for the work
•IJDP favours clear organisation of papers, an economical writing style, and a modest tone.

Art work

Submitting your illustrations, pictures, tables and other artwork in an electronic format helps us to produce your work to the best possible standards, ensuring accuracy, clarity and a high level of detail.

General points

•Always supply high-quality print outs of your artwork, in case conversion of the electronic artwork is problematic.
•Make sure you use a uniform lettering and sizing of your original artwork.
•Save text in illustrations as"graphics"or enclose the font.
•Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol.
•Number the illustrations according to their sequence in the text.
•Use a logical naming convention for your artwork files, and supply a separate listing of the files and the software used.
•Provide all illustrations as separate files and as hardcopy print outs on separate sheets.
•Provide captions to illustrations separately.
•Produce images near to the desired size of the printed version.
A detailed guide on electronic artwork is available on our website: External link http://authors.elsevier.com/artwork

Supplementary data

Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products including ScienceDirect: External link http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file.

Files can be stored on 3.5 inch diskette, ZIP disk or CD (either MS-DOS or Macintosh).

Colour reproduction

Submit colour illustrations as original photographs, high quality computer prints or transparencies, close to the size expected in publication, or as 35mm slides. Please make sure that artwork files are in acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. Polaroid colour prints are not suitable. If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g. ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. For further information on the preparation of electronic artwork, please see External link http://authors.elsevier.com/artwork

Please note: Because of technical complications which can arise by converting colour figures to "grey scale" (for printed version should you not opt for colour in print) please submit in addition usable black and white versions of all colour illustrations.

References

Text: Citations in the text should follow the referencing style used by the American Psychological Association. You are referred to the Publication Manual; of the American Psychological Association, Fourth Edition, ISBN 1-55798-243-0, copies of which my be ordered from PAP Order Dept, P.O.B. 2710 Hyattsville, MD 20784, USA or APA, 3 Henriette Street, London EC3E 8LU, UK.

Details concerning this referencing style can also be found at External link http://humanities.byu.edu/linguistics/henrichsen/APA/APA01.html

List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters "a", "b". "c" etc placed after the year of publication.

Examples

Reference to a journal publication:
Van der Geer, J, Hanraads, J.A.J., & Lupton, R.A. (2000). The art of writing a scientific article. Journal of Scientific Communications,163, 51-59

Reference to a book:
Strunk, W., Jr., & White, E.B. (1979). The elements of style. (3rd ed.) New York: Macmilllan, (Chapter 4).

Reference to a chapter in an edited book:
Mettam, G. R., & Adams, L. B. (1994). How to prepare an electronic version of your article. In B. S. Jones, & R. Z. Smith (Eds), Introduction to the electronic age (pp.281-304. New York: E-Publishing inc.

Reference to a website must contain the date on which the information was retrieved:

Gerlach R, Schneider W. Injecting room at INDRO, Munster, Germany. Retrieved 2nd June 2002 from External link http://www.indro-online.de/sir.htm

Copyright transfer

Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright see External link http://authors.elsevier.com. This transfer will ensure the widest possible dissemination of information.

If excerpts from other copyrighted works are included, the Author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has pre-printed forms for use by Authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 238 7869, fax (+1) 215 238 2239, e-mail healthpermissions@elsevier.com. Requests may also be completed on-line via the Elsevier homepage (External link http://www.elsevier.com/locate/permissions)

Proofs and page charge

One set of proofs will be sent to the corresponding author. No alteration of the substance of the text, tables, or figures will be allowed at this stage. Corrected proofs should be returned to the publisher within two days of receipt. Authors who submit to the journal will be given access to Elsevier's On-Line Author Status Information System (OASIS). They will receive a personal identification code together with the acknowledgement letter sent upon receipt of their manuscript. This code will grant them access to the OASIS site on the internet, allowing them to track the status of their manuscript. Authors may also access Elsevier's central Log-in Department e-mail address for any specific questions they may have regarding the publication of their manuscript. The International Journal of Drug Policy carries no page charges.

Language editing

Language editing: International Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific, technical and medical journals and need assistance before they submit their article or, before it is accepted for publication. Authors can contact these services directly: International Science Editing External link http://www.internationalscienceediting.com and Asia Science Editing External link http://www.asiascienceediting.com or, for more information about language editing services, please contact authorsupport@elsevier.com who will be happy to deal with any questions. For more information please check: External link http://www.elsevier.com/locate/languagepolishing

Author enquiries

For enquiries relating to the submission of articles please visit Elsevier's Author Gateway at External link http://authors.elsevier.com. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more.

All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to Elsevier Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, Tel: +353 61 709600, Fax: +353 61 709113.

Offprints

Fifty offprints are provided free of charge to the corresponding author, and additional copies (minimum 100) can be ordered at prices shown on the price list accompanying the Offprint Order which will be sent with the proofs.

Policy and ethics

For work described in your article involving human experimental investigations of any kind, must have been carried out in accordance with The Code of Ethics of the Declaration of Helsinki; External link http://www.wma.net/e/policy/b3.htm


Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit External link http://www.elsevier.com/fundingbodies
Editorial Board

Editorial Board


Editors-in-Chief

Tim Rhodes
Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, London, UK
Gerry Stimson
International Harm Reduction Association, London, UK


Associate Editors

Evan Wood
University of British Columbia, Vancouver, Canada
Paul Dietze
Turning Point, Melbourne, Australia
David Moore
Curtin University, Perth, Australia
Robert Power
Centre for Harm Reduction, Burnet Institute, Melbourne, Australia
Sam Friedman
National Development & Research Institutes, New York, USA
Scott Burris
Temple University Beasley School of Law, Philadelphia, USA


Editors' Assistants

Gillian Hunter
UK
Jo Kimber
UK


Book Review Editors

Francisco Bastos
Brazil
Susan Sherman
USA


Editorial Board

Andrew Ball
Switzerland
Francisco Bastos
Brazil
David Bewley-Taylor
UK
Chris Bonell
UK
Philippe Bourgois
USA
Dave Burrows
Australia
Waleska Caiaffa
Brazil
Michael Clatts
USA
Hannah Cooper
USA
Nick Crofts
Australia
John Fitzgerald
Australia
Craig Fry
Australia
Christine Godfrey
UK
Robert Heimer
USA
Adeeba Kamarulzaman
Malaysia
Thomas Kerr
Canada
Suresh Kumar
India
Harry Levine
USA
Rick Lines
UK
David MacDonald
UK
Lisa Maher
Australia
Monica Malta
Brazil
Jim McCambridge
UK
Jo Neale
UK
Samiran Panda
India
Afarin Rahimi
Iran
Craig Reinarman
USA
Peter Reuter
USA
Ann Roche
Australia
Diana Rossi
Argentina
Mukta Sharma
India
Susan Sherman
USA
Merrill Singer
USA
Nick Stafford
Australia
Steffanie Strathdee
USA
Carla Treloar
Australia
Peter Vickerman
UK
Daniel Wolfe
USA


 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2008 武汉大学图书馆版权所有